Historical record - last NADAC effective date: 9/23/2015
Product Information
ROBITUSSIN PEDIATRIC COUGH SYP is a brand product labeled by Haleon US Holdings LLC, priced at $0.0377 per ML under NDC 00031869412. Its NADAC has been published 97 times since Nov 28, 2013.
Strength
7.5 mg/5mL
Manufacturer
Haleon US Holdings LLCNDC
00031869412
Classification
Brand
Dosage Form
LIQUID
Route
ORAL
Effective Date
9/23/2015
Active Ingredients
DEXTROMETHORPHAN HYDROBROMIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
1/1/2004
Pharmacological Classes
Price Statistics
The NADAC for ROBITUSSIN PEDIATRIC COUGH SYP has been published 97 times since Nov 28, 2013, and over the history we have for it it has risen 4.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0377 per ML |
|---|---|
| All-time high | $0.0377 (Sep 30, 2015) |
| All-time low | $0.0351 (Apr 23, 2014) |
| Median price | $0.0365 |
| Average price | $0.0364 |
| Largest weekly change | +4.4% (Aug 20, 2014) |
| Weeks tracked | 97 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+4.8%
Last surveyed Sep 30, 2015 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the dextromethorphan hydrobromide market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Haleon US Holdings LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
dextromethorphan hydrobromide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Sigma-1 Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ROBITUSSIN PEDIATRIC COUGH SYP?
The current National Average Drug Acquisition Cost (NADAC) for ROBITUSSIN PEDIATRIC COUGH SYP, manufactured by Haleon US Holdings LLC, is $0.0377 per ML (NDC 00031869412), effective Sep 30, 2015.
How has the price of ROBITUSSIN PEDIATRIC COUGH SYP changed over time?
Over the history we have for it, the NADAC for ROBITUSSIN PEDIATRIC COUGH SYP has risen 4.8%. It has been tracked across 97 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ROBITUSSIN PEDIATRIC COUGH SYP?
Since Nov 28, 2013, the NADAC for ROBITUSSIN PEDIATRIC COUGH SYP has ranged from a low of $0.0351 (Apr 23, 2014) to a high of $0.0377 (Sep 30, 2015), with a median of $0.0365 per ML.
Are there cheaper alternatives to ROBITUSSIN PEDIATRIC COUGH SYP?
No other NADAC-published product currently shares the active ingredient and strength of ROBITUSSIN PEDIATRIC COUGH SYP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ROBITUSSIN PEDIATRIC COUGH SYP?
ROBITUSSIN PEDIATRIC COUGH SYP (NDC 00031869412) is labeled by Haleon US Holdings LLC, and CMS classifies it as a brand product.